WILSON DISEASE
WEBINAR:
MAR 19, 2026
6:00pm to 7:00pm PDT
Do you know about Wilson Disease, a rare liver condition? Wilson disease is an inherited disorder that causes copper to build up in the liver, brain, and other organs. Liver-related symptoms include vomiting, weakness, fluid build-up in the abdomen, swelling of the legs, yellow skin and itchiness. Brain-related symptoms include tremors, muscle stiffness, trouble in speaking, personality changes, anxiety, and psychosis.
​
While copper plays a vital role in the healthy development of nerves and bones, too much copper is toxic. Most people with the condition are born with it, but symptoms often don't appear until later in life.
​
​To learn more about this complicated rare disease and have your questions answered, please register to join us.
TRANSITION OF CARE
WEBINAR:
MAY 7, 2026
6:00pm to 7:00pm PDT
You are cordially invited to join us for a free educational webinar on “Transition of Care.” During this webinar we will address the difficulties and details of Transferring liver patients’ care from pediatrics to adulthood as they grow up and life situations change. This is particularly important for those pediatric liver patients who are, or will be, in the process of moving to other States to continue their college education.
Transition of Care is a subject that we hardly hear about but is one of the most important turning points in the lives of thousands of young liver patients.
​
Joining Dr. Kohli during the roundtable discussion are Ms. Kristine and Ms. Molly Clark, Ms. Cheri and Mr. Malakai Carey, Ms. Maria Bakhru and Mr. Aaron Jackson.
Please join us as we focus on this issue and dig deep to bring clarity and much needed information and help to all.
Metabolic Dysfunction- Associated Steatohepatitis (MASH)
WEBINAR:
JUN 18, 2026
6:00pm to 7:00pm PDT
In recognition of Fatty Liver Disease Day (June 11th), Liver Health Foundation is hosting an educational webinar on MASH or Metabolic Dysfunction-Associated Steatohepatitis on June 19th, to shed more light on this global epidemic and discuss the newest treatment options for this disease.
​
MASH is a serious liver disease characterized by the buildup of fat in the liver (steatosis), leading to inflammation and liver cell damage. It is part of a broader condition called metabolic dysfunction-associated steatotic liver disease (MASLD), which occurs in people who do not consume significant amounts of alcohol. The condition is strongly linked to metabolic issues such as obesity, insulin resistance, type 2 diabetes, high blood pressure, and abnormal cholesterol levels. Without treatment, MASH can progress to liver fibrosis, cirrhosis, liver failure, or liver cancer, requiring liver transplant.​
​
We invite you to join this free educational webinar and learn how to protect your liver and your life. During the webinar our expert hepatologists will respond to your questions.
LYSOSOMAL ACID LIPASE DEFICIENCY (LAL-D)
WEBINAR:
JUL 16, 2026
6:00pm to 7:00pm PDT
You are kindly invited to attend an educational webinar on Lysosomal Acid Lipase deficiency (LAL-D), characterized by the body’s inability to properly break down and utilize certain fats. When fats are not broken down and used, they accumulate in many of the body’s cells, tissues and organs and eventually lead to signs of liver disease. There are two types of LAL-D.
​
-
Infantile LAL-D is present early in infancy and is less common and more severe than late-onset LAL-D. Children with infantile-onset LAL-D generally begin exhibiting signs of the disease shortly after birth as fat molecules begin to accumulate throughout the body.
-
Late-onset LAL-D is generally present in mid-childhood. Children with late-onset LAL-D show great variation in their symptoms and the age at which signs of the disease begin to show. While many have their first symptoms in mid-childhood, some first develop symptoms in adolescence or even adulthood.
Please join us to learn more about LAL-D, on July 26, 2026. Our expert speakers will discuss this disease and will respond to your questions.
